Model-Based Efficacy and Toxicity Comparisons of Moxifloxacin for Multidrug-Resistant Tuberculosis

BACKGROUND: Moxifloxacin (MOX) is used as a first-choice drug to treat multidrug-resistant tuberculosis (MDR-TB); however, evidence-based dosing optimization should be strengthened by integrative analysis. The primary goal of this study was to evaluate MOX efficacy and toxicity using integrative mod...

Descripción completa

Detalles Bibliográficos
Autores principales: Yun, Hwi-Yeol, Chang, Vincent, Radtke, Kendra K, Wang, Qianwen, Strydom, Natasha, Chang, Min Jung, Savic, Radojka M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825669/
https://www.ncbi.nlm.nih.gov/pubmed/35146045
http://dx.doi.org/10.1093/ofid/ofab660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825669/
https://www.ncbi.nlm.nih.gov/pubmed/35146045
http://dx.doi.org/10.1093/ofid/ofab660

Ejemplares similares